Krystal Biotech, Inc. (KRYS)
274.81
-10.23
(-3.59%)
USD |
NASDAQ |
Jan 20, 16:00
274.81
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Market Cap: 7.969B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.415B |
| DexCom, Inc. | 27.59B |
| CorMedix, Inc. | 542.07M |
| ADMA Biologics, Inc. | 4.186B |
| Moderna, Inc. | 16.80B |
Market Cap Related Metrics
| PE Ratio | 41.22 |
| PS Ratio | 21.97 |
| PEG Ratio | 0.1487 |
| Price to Book Value | 7.003 |
| Price to Free Cash Flow | 49.51 |
| Price | 274.81 |
| Earnings Yield | 2.43% |
| PEGY Ratio | 0.1487 |
| Operating PE Ratio | 51.81 |
| Normalized PE Ratio | 41.22 |